We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNH
3301
CNH Industrial
CNH
$17.5B
$3K ﹤0.01%
460
-7,767
-94% -$54.4K
CSCI
3302
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$3K ﹤0.01%
+7
New +$2.61K
MTVA
3303
MetaVia Inc
MTVA
$7.69M
0
AUMN
3304
DELISTED
Golden Minerals Company
AUMN
$3K ﹤0.01%
132
TWOU
3305
DELISTED
2U Inc
TWOU
$3K ﹤0.01%
+4
New +$4.08K
TGH
3306
DELISTED
Textainer Group Holdings limited
TGH
$3K ﹤0.01%
411
-1,973
-83% -$16.4K
NEPT
3307
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$3K ﹤0.01%
1
PCTI
3308
DELISTED
PCTEL, Inc. Common Stock
PCTI
$3K ﹤0.01%
467
+367
+367% +$1.91K
HEP
3309
DELISTED
Holly Energy Partners, L.P.
HEP
$3K ﹤0.01%
100
-5,012
-98% -$163K
IHIT
3310
DELISTED
Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share
IHIT
$3K ﹤0.01%
+300
New +$3.06K
AMRS
3311
DELISTED
Amyris Inc.
AMRS
$3K ﹤0.01%
240
-497
-67% -$6.09K
SNMP
3312
DELISTED
Evolve Transition Infrastructure LP
SNMP
$3K ﹤0.01%
+8
New +$3.05K
IVC
3313
DELISTED
Invacare Corporation
IVC
$3K ﹤0.01%
+233
New +$2.68K
VIVO
3314
DELISTED
Meridian Bioscience Inc
VIVO
$3K ﹤0.01%
+174
New +$3.06K
EXTN
3315
DELISTED
Exterran Corporation
EXTN
$3K ﹤0.01%
129
-33
-20% -$626
GBT
3316
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3K ﹤0.01%
+200
New +$3.51K
BRG
3317
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$3K ﹤0.01%
+233
New +$2.98K
WMC
3318
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$3K ﹤0.01%
33
-236
-88% -$24.4K
PVG
3319
DELISTED
PRETIUM RESOURCES INC.
PVG
$3K ﹤0.01%
310
-11,109
-97% -$98K
CVA
3320
DELISTED
Covanta Holding Corporation
CVA
$3K ﹤0.01%
+200
New +$2.97K
BOCH
3321
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$3K ﹤0.01%
264
-1,437
-84% -$11.5K
OTEL
3322
DELISTED
Otelco, Inc. Class A
OTEL
$3K ﹤0.01%
505
-195
-28% -$1.06K
SNDE
3323
DELISTED
Sundance Energy Inc. Common Stock
SNDE
$3K ﹤0.01%
+20
New +$2.83K
DUC
3324
DELISTED
Duff & Phelps Utility & Corporate Bond Trust
DUC
$3K ﹤0.01%
350
-350
-50% -$3.27K
NGHC
3325
DELISTED
National General Holdings Corp
NGHC
$3K ﹤0.01%
+118
New +$2.68K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.